$DV
DoubleVerify Holdings, Inc.

2024 Q2 Form 10-Q Financial Statement

#000155837024007053 Filed on May 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $155.9M $140.8M $122.6M
YoY Change 16.56% 14.84% 26.75%
Cost Of Revenue $26.10M $26.62M $23.95M
YoY Change -0.34% 11.13% 41.92%
Gross Profit $129.8M $114.2M $98.64M
YoY Change 20.67% 15.74% 23.54%
Gross Profit Margin 83.26% 81.09% 80.46%
Selling, General & Admin $67.93M $59.95M $45.90M
YoY Change 32.44% 30.6% -0.99%
% of Gross Profit 52.34% 52.51% 46.53%
Research & Development $39.81M $36.39M $28.56M
YoY Change 24.62% 27.45% 32.27%
% of Gross Profit 30.67% 31.88% 28.95%
Depreciation & Amortization $3.900M $10.93M $8.983M
YoY Change -59.69% 21.65% -0.63%
% of Gross Profit 3.0% 9.57% 9.11%
Operating Expenses $107.7M $96.34M $74.46M
YoY Change 15.96% 29.39% 9.58%
Operating Profit $11.05M $6.895M $15.20M
YoY Change -24.55% -54.65% 431.79%
Interest Expense $233.0K $232.0K $256.0K
YoY Change -194.33% -9.38% 10.34%
% of Operating Profit 2.11% 3.36% 1.68%
Other Income/Expense, Net $2.064M $2.272M $2.734M
YoY Change -16.64% -16.9% -6043.48%
Pretax Income $12.88M $8.935M $17.68M
YoY Change -23.67% -49.47% 585.08%
Income Tax $5.400M $1.800M $5.500M
% Of Pretax Income 41.93% 20.15% 31.11%
Net Earnings $7.474M $7.156M $12.18M
YoY Change -41.79% -41.22% 165.89%
Net Earnings / Revenue 4.79% 5.08% 9.93%
Basic Earnings Per Share $0.04 $0.04 $0.07
Diluted Earnings Per Share $0.04 $0.04 $0.07
COMMON SHARES
Basic Shares Outstanding 171.8M 171.3M 165.5M
Diluted Shares Outstanding 176.0M 176.1M 171.7M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $338.8M $334.3M $285.7M
YoY Change 14.68% 17.01% 35.04%
Cash & Equivalents $256.1M $302.0M $285.7M
Short-Term Investments $82.75M $32.31M
Other Short-Term Assets $32.98M $20.36M $16.70M
YoY Change 59.19% 21.93% -33.16%
Inventory
Prepaid Expenses
Receivables $187.8M $195.6M $174.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $559.6M $550.3M $476.7M
YoY Change 13.69% 15.45% 28.62%
LONG-TERM ASSETS
Property, Plant & Equipment $64.52M $60.85M $48.84M
YoY Change -44.99% 24.59% 155.02%
Goodwill $431.5M $432.9M $343.9M
YoY Change 25.55% 25.88% 0.35%
Intangibles $125.4M $132.8M $129.4M
YoY Change 1.99% 2.68% -16.28%
Long-Term Investments
YoY Change
Other Assets $1.727M $1.810M $1.701M
YoY Change -73.67% 6.41% -25.53%
Total Long-Term Assets $713.1M $709.9M $588.2M
YoY Change 20.76% 20.69% -1.16%
TOTAL ASSETS
Total Short-Term Assets $559.6M $550.3M $476.7M
Total Long-Term Assets $713.1M $709.9M $588.2M
Total Assets $1.273B $1.260B $1.065B
YoY Change 17.55% 18.34% 10.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $10.60M $12.76M $10.67M
YoY Change 20.0% 19.57% 179.3%
Accrued Expenses $44.14M $34.22M $25.49M
YoY Change -3.62% 34.27% -2.69%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $2.393M $2.640M $1.615M
YoY Change -23.77% 63.47% -20.33%
Total Short-Term Liabilities $79.53M $75.37M $76.01M
YoY Change 20.04% -0.84% 70.09%
LONG-TERM LIABILITIES
Long-Term Debt $1.844M $2.344M $497.0K
YoY Change -53.17% 371.63% -75.67%
Other Long-Term Liabilities $2.815M $2.752M $3.415M
YoY Change -96.35% -19.41% 44.58%
Total Long-Term Liabilities $2.815M $2.752M $3.415M
YoY Change -96.53% -19.41% 44.58%
TOTAL LIABILITIES
Total Short-Term Liabilities $79.53M $75.37M $76.01M
Total Long-Term Liabilities $2.815M $2.752M $3.415M
Total Liabilities $167.5M $163.1M $161.7M
YoY Change 12.82% 0.89% 6.36%
SHAREHOLDERS EQUITY
Retained Earnings $213.6M $206.1M $139.7M
YoY Change 40.05% 47.57% 57.26%
Common Stock $173.0K $172.0K $166.0K
YoY Change 3.59% 3.61% 1.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.105B $1.097B $903.2M
YoY Change
Total Liabilities & Shareholders Equity $1.273B $1.260B $1.065B
YoY Change 17.55% 18.34% 10.27%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $7.474M $7.156M $12.18M
YoY Change -41.79% -41.22% 165.89%
Depreciation, Depletion And Amortization $3.900M $10.93M $8.983M
YoY Change -59.69% 21.65% -0.63%
Cash From Operating Activities $35.88M $31.77M $21.43M
YoY Change 234.15% 48.3% -1052.69%
INVESTING ACTIVITIES
Capital Expenditures $7.165M $6.393M $4.099M
YoY Change 100.59% 55.96% -13.87%
Acquisitions
YoY Change
Other Investing Activities -$49.73M -$32.21M
YoY Change
Cash From Investing Activities -$56.89M -$38.60M -$4.099M
YoY Change 1492.69% 841.79% -13.87%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -23.65M -912.0K 466.0K
YoY Change -993.13% -295.71% -114.97%
NET CHANGE
Cash From Operating Activities 35.88M 31.77M 21.43M
Cash From Investing Activities -56.89M -38.60M -4.099M
Cash From Financing Activities -23.65M -912.0K 466.0K
Net Change In Cash -44.66M -8.119M 17.92M
YoY Change -555.06% -145.3% -279.42%
FREE CASH FLOW
Cash From Operating Activities $35.88M $31.77M $21.43M
Capital Expenditures $7.165M $6.393M $4.099M
Free Cash Flow $28.72M $25.38M $17.33M
YoY Change 300.73% 46.48% -347.25%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001819928
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
001-40349
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
DoubleVerify Holdings, Inc.
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
82-2714562
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
462 Broadway
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10013
CY2024Q1 dei City Area Code
CityAreaCode
212
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
631-2111
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
CY2024Q1 dei Trading Symbol
TradingSymbol
DV
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
171796441
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
302017000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
310131000
CY2024Q1 us-gaap Short Term Investments
ShortTermInvestments
32312000
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9580000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
9442000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
195638000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
206941000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
20356000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
15930000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
550323000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
533002000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60851000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58020000
CY2024Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
64910000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
60470000
CY2024Q1 us-gaap Goodwill
Goodwill
432865000
CY2023Q4 us-gaap Goodwill
Goodwill
436008000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
132815000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
140883000
CY2024Q1 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
16619000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
13077000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1810000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1571000
CY2024Q1 us-gaap Assets
Assets
1260193000
CY2023Q4 us-gaap Assets
Assets
1243031000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
12761000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
12932000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34218000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44264000
CY2024Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9844000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
9029000
CY2024Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
6064000
CY2023Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
5833000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2640000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
2934000
CY2024Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
9841000
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
8863000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
75368000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
83855000
CY2024Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
75124000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
71563000
CY2024Q1 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2344000
CY2023Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
2865000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
7514000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
8119000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2752000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2690000
CY2024Q1 us-gaap Liabilities
Liabilities
163102000
CY2023Q4 us-gaap Liabilities
Liabilities
169092000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171756000
CY2024Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
171724000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
1000000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
171168000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
171146000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
172000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
171000
CY2024Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
899354000
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
878331000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
32000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
22000
CY2024Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1146000
CY2023Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
743000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
206139000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
198983000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-7428000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2803000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1097091000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1073939000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1260193000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1243031000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140782000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
122594000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26618000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
23952000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
36394000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
28555000
CY2024Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
37872000
CY2023Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
25712000
CY2024Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
22075000
CY2023Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
20188000
CY2024Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
10928000
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8983000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
6895000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
15204000
CY2024Q1 us-gaap Interest Expense
InterestExpense
232000
CY2023Q1 us-gaap Interest Expense
InterestExpense
256000
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2272000
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2734000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
8935000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17682000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1779000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5507000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
7156000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12175000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
171306000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165631000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176124000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171657000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
7156000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12175000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4625000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1193000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
2531000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
13368000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1073939000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-4625000
CY2024Q1 dvh Stock Repurchased During Period Value Held In Treasury
StockRepurchasedDuringPeriodValueHeldInTreasury
1792000
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
20718000
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1695000
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
7156000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1097091000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
876859000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
1193000
CY2023Q1 dvh Stock Repurchased During Period Value Held In Treasury
StockRepurchasedDuringPeriodValueHeldInTreasury
787000
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11992000
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1766000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12175000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
903198000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
7156000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
12175000
CY2024Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
907000
CY2023Q1 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1285000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
10928000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
8983000
CY2024Q1 dvh Amortization Of Debt Issuance Costs
AmortizationOfDebtIssuanceCosts
74000
CY2023Q1 dvh Amortization Of Debt Issuance Costs
AmortizationOfDebtIssuanceCosts
74000
CY2024Q1 dvh Non Cash Lease Expenses
NonCashLeaseExpenses
1569000
CY2023Q1 dvh Non Cash Lease Expenses
NonCashLeaseExpenses
1658000
CY2024Q1 dvh Deferred Income Tax Expense Benefit And Adjustments
DeferredIncomeTaxExpenseBenefitAndAdjustments
-3963000
CY2023Q1 dvh Deferred Income Tax Expense Benefit And Adjustments
DeferredIncomeTaxExpenseBenefitAndAdjustments
-5382000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
20241000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11813000
CY2024Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-64000
CY2024Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
677000
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-2000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-9626000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8052000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5218000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
6874000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
55000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
3700000
CY2024Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-10342000
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
2048000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
31774000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
21426000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6393000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
4099000
CY2024Q1 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
32211000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38604000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4099000
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
50000000
CY2023Q1 us-gaap Repayments Of Long Term Lines Of Credit
RepaymentsOfLongTermLinesOfCredit
50000000
CY2024Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1695000
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1766000
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
815000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
513000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1792000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
787000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-912000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
466000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-377000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
131000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-8119000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
17924000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
310257000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
267938000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302138000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
285862000
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
302017000
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
285738000
CY2024Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
121000
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
124000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302138000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
285862000
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1324000
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1708000
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
74000
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
266000
CY2024Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
6207000
CY2023Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1415000
CY2024Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
45000
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
378000
CY2024Q1 dvh Share Based Compensation Included In Capitalized Software Development Costs
ShareBasedCompensationIncludedInCapitalizedSoftwareDevelopmentCosts
471000
CY2023Q1 dvh Share Based Compensation Included In Capitalized Software Development Costs
ShareBasedCompensationIncludedInCapitalizedSoftwareDevelopmentCosts
179000
CY2024Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
122594000
CY2024Q1 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
55100000
CY2024Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;"><b style="font-weight:bold;text-decoration-color:#000000;text-decoration-line:underline;text-decoration-style:solid;">Use of Estimates and Judgments in the Preparation of the Condensed Consolidated Financial Statements</b></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenue and expense during the reporting periods. Significant estimates and judgments are inherent in the analysis and measurement of items including, but not limited to: revenue recognition criteria including the determination of principal versus agent revenue considerations, income taxes, the valuation and recoverability of goodwill and intangible assets, the assessment of potential loss from contingencies, assumptions in valuing acquired assets and liabilities assumed in business combinations, the allowance for doubtful accounts, and assumptions used in determining the fair value of stock-based compensation. Management bases its estimates and assumptions on historical experience and on various other factors that are believed to be reasonable under the circumstances. Due to the inherent uncertainty involved in making estimates, actual results reported in future periods may be affected by changes in those estimates. These estimates are based on the information available as of the date of the Condensed Consolidated Financial Statements<i style="font-style:italic;">.</i></p>
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
140782000
CY2023Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
55000000.0
CY2024Q1 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
13900000
CY2023Q4 us-gaap Goodwill
Goodwill
436008000
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
3143000
CY2024Q1 us-gaap Goodwill
Goodwill
432865000
CY2024Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
264928000
CY2024Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
132113000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
132815000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
265986000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
125103000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
140883000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7300000
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6200000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
21417000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
26751000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
21997000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
18081000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
14928000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
12577000
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
17064000
CY2024Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
132815000
CY2023Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2024Q1 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
0
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
41326000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
37797000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60851000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
58020000
CY2024Q1 us-gaap Depreciation
Depreciation
3600000
CY2023Q1 us-gaap Depreciation
Depreciation
2700000
CY2024Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2637000
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
2587000
CY2024Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
619000
CY2023Q1 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
217000
CY2024Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
64000
CY2023Q1 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
23000
CY2024Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
317000
CY2023Q1 us-gaap Short Term Lease Cost
ShortTermLeaseCost
246000
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
267000
CY2024Q1 us-gaap Lease Cost
LeaseCost
3637000
CY2023Q1 us-gaap Lease Cost
LeaseCost
2806000
CY2024Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
2516000
CY2023Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
1336000
CY2024Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
74000
CY2023Q1 us-gaap Finance Lease Interest Payment On Liability
FinanceLeaseInterestPaymentOnLiability
23000
CY2024Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
815000
CY2023Q1 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
513000
CY2024Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P12Y10M24D
CY2023Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P13Y10M24D
CY2024Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2023Q1 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P1Y4M24D
CY2024Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.047
CY2023Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.045
CY2024Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.054
CY2023Q1 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.037
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
7802000
CY2024Q1 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
2325000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
9410000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
2150000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
8140000
CY2024Q1 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
819000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
7586000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
7731000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
8154000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
67157000
CY2024Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
115980000
CY2024Q1 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
5294000
CY2024Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
31012000
CY2024Q1 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
310000
CY2024Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
84968000
CY2024Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
4984000
CY2023Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
CY2024Q1 us-gaap Operating Lease Impairment Loss
OperatingLeaseImpairmentLoss
0
CY2024Q1 dvh Line Of Credit Facility Maximum Total Leverage Ratio
LineOfCreditFacilityMaximumTotalLeverageRatio
3.5
CY2024Q1 dvh Line Of Credit Facility Minimum Fixed Charge Coverage Ratio
LineOfCreditFacilityMinimumFixedChargeCoverageRatio
1.25
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1800000
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.199
CY2024Q1 dvh Effective Income Tax Rate Reconciliation Discrete Items
EffectiveIncomeTaxRateReconciliationDiscreteItems
-0.109
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5500000
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.311
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
7156000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
12175000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
171306000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
165631000
CY2024Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
4818000
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
6026000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
176124000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
171657000
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6200000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
7100000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9992000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.01
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y10M28D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
197598000
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
194000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
8.78
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
23000
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
28.49
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
9775000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
17.15
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y8M1D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
176726000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2744000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
25.70
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P8Y25D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
26257000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
6906000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
13.58
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y29D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
149377000
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
5100000
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
12800000
CY2024Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
20241000
CY2023Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
11813000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
217700000
CY2024Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y6M
CY2024Q1 dvh Accrued Vendor Payments Current
AccruedVendorPaymentsCurrent
7506000
CY2023Q4 dvh Accrued Vendor Payments Current
AccruedVendorPaymentsCurrent
6286000
CY2024Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
9793000
CY2023Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
20809000
CY2024Q1 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
11526000
CY2023Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
10602000
CY2024Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
1026000
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Current Liabilities
PensionAndOtherPostretirementDefinedBenefitPlansCurrentLiabilities
2982000
CY2024Q1 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
4367000
CY2023Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
3585000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
34218000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
44264000
CY2024Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
3279000
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
2756000
CY2024Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-978000
CY2023Q1 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-20000
CY2024Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
29000
CY2023Q1 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
2000
CY2024Q1 dvh Other Income Net
OtherIncomeNet
2272000
CY2023Q1 dvh Other Income Net
OtherIncomeNet
2734000
CY2024Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1

Files In Submission

Name View Source Status
dv-20240331_cal.xml Edgar Link unprocessable
0001558370-24-007053-index-headers.html Edgar Link pending
0001558370-24-007053-index.html Edgar Link pending
0001558370-24-007053.txt Edgar Link pending
0001558370-24-007053-xbrl.zip Edgar Link pending
dv-20240331.xsd Edgar Link pending
dv-20240331x10q.htm Edgar Link pending
dv-20240331xex31d1.htm Edgar Link pending
dv-20240331xex31d2.htm Edgar Link pending
dv-20240331xex32d1.htm Edgar Link pending
dv-20240331xex32d2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
dv-20240331_def.xml Edgar Link unprocessable
dv-20240331_lab.xml Edgar Link unprocessable
dv-20240331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
dv-20240331x10q_htm.xml Edgar Link completed
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending